Skip to main content

Medications

Feature content

Joint forces boxing gloves

10-14-2020 | Type 2 diabetes | Editorial | Article

Tirzepatide: A new challenger for type 2 diabetes management?

What does the future hold for the novel agent tirzepatide, a GIP/GLP-1 co-agonist? John Wilding examines what we know so far.

Sanjay Kalra, Lori Berard, John Wilding

10-07-2020 | EASD 2020 | Conference coverage | Article

EASD 2020: Editorial Board conference highlights

Listen to Sanjay Kalra, John Wilding and Lori Berard reflecting on their research highlights of this year’s virtual 56th EASD Annual Meeting (39:05).

Kirsty Winkley

10-01-2020 | Psychosocial care | Podcast | Article

Why psychosocial care matters: Optimal medication taking in diabetes

Kirsty Winkley discusses why people with diabetes can find it so challenging to take medications optimally and consistently, and what healthcare providers can do to help (24:50).

ADA highlights 4by3

06-24-2020 | ADA 2020 | Conference coverage | Article

ADA 2020 goes virtual! Editorial Board conference highlights

Listen to our Editorial Board reflecting on their ADA scientific highlights, and its novel virtual format (34:17).

Rayhan Lal

06-23-2020 | ADA 2020 | Podcast | Article

Expert commentary: Closed-loop insulin delivery research update

Engineer turned endocrinologist Rayhan Lal reflects on the shape of artificial pancreas research and what changes are needed to best benefit people with diabetes (18:54).

Balancing pros and cons

05-06-2020 | Type 2 diabetes | Editorial | Article

Oral semaglutide: A technical triumph, with caveats

Diabetologist and Editorial Board member John Wilding gives his opinion on the latest addition to the GLP-1RA class, oral semaglutide.

Neil Skolnik

04-29-2020 | Type 2 diabetes | Podcast | Article

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes?

US primary care physician Neil Skolnik discusses the role of oral semaglutide in the care of people with type 2 diabetes and outlines key considerations for its use (12:26).

New Year transition

03-03-2020 | Guidelines | Editorial | Article

Standards of Medical Care in Diabetes: A 2020 Update from the American Diabetes Association

Sanjay Kalra, Diabetologist and Editorial Board member, outlines what's new in the American Diabetes Association’s 2020 Standards of Care update. 

A selection of KwikPens from Lilly Diabetes

12-17-2019 | Insulin | Editorial | Article

How can we optimize titration with new basal insulins?

Nurse and Diabetes Educator Lori Berard highlights the advantages of “concentrated” insulins and outlines her recommendations for getting titration right for patients.

Jay Shubrook, Katherine Tuttle

11-27-2019 | Nephropathy | Video | Article

The revolution is here: New treatments for diabetic kidney disease

Katherine Tuttle and Jay Shubrook reconvene to discuss what the landmark findings from recent renal outcomes trials mean for clinical practice (16:51).

09-24-2019 | Type 2 diabetes | Podcast | Article

How was it for you? The experts discuss EASD 2019

Our clinical advisors discuss their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial.

Cardiorenal syndromes and SGLT2 inhibitor usage

08-06-2019 | SGLT2 inhibitors | Editorial | Article

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity.

Files

07-03-2019 | Semaglutide | At a glance | Article

A quick guide to the PIONEER trials

medwireNews rounds up the ongoing, reported, and published trials from the PIONEER oral semaglutide program.

Kamlesh Khunti

07-02-2019 | Dulaglutide | Podcast | Article

REWIND, DECLARE, and high-risk diabetes patients

How will the findings of the REWIND trial and the DECLARE-TIMI 58 renal outcomes analysis affect treatment decisions for high-risk diabetes patients without overt cardiovascular disease? medwireNews asks Kamlesh Khunti.

Doctor patient consultation

06-26-2019 | SGLT2 inhibitors | Feature | Article

Fournier gangrene: A challenge for risk–benefit communication

The recent postmarketing data on Fournier gangrene in people taking sodium-glucose cotransporter 2 inhibitors has increased concerns about this very rare but potentially fatal side effect. medwireNews talks to primary care diabetes specialist Kevin Fernando about how the findings affect risk–benefit considerations.

Sulfonylurea pill

05-22-2019 | Sulfonylureas | Editorial | Article

The CAROLINA trial: Make or break for sulfonylureas?

Diabetologist Sanjay Kalra puts the CAROLINA trial into historical context and considers the present-day implications for the use of DPP-4 inhibitors and sulfonylureas.

Andrew Frankel

04-17-2019 | Nephropathy | Podcast | Article

Nephrologist expert commentary: The CREDENCE trial

Consultant nephrologist Andrew Frankel tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes (9:45).

Kevin Fernando

04-17-2019 | Nephropathy | Podcast | Article

Primary care expert commentary: The CREDENCE trial

General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

Vlado Perkovic

04-15-2019 | Nephropathy | Podcast | Article

Researcher comment: The CREDENCE trial

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice (6:51).

Jay Shubrook, Katherine Tuttle

04-13-2019 | Nephropathy | Video | Article

Diabetic kidney disease: A call to primary care

Nephrologist and Endocrinologist Katherine Tuttle joins Primary Care Physician Jay Shubrook to share best practice tips for kidney disease screening in patients with diabetes (8:16).